CorrespondenceResearch into end-of-life cancer care—investment is needed
References (4)
Critical conversations: navigating between hope and truth
Lancet
(2011)- et al.
Delivering affordable cancer care in high income countries
Lancet Oncol
(2011)
Cited by (25)
Integration of oncology and palliative care: a Lancet Oncology Commission
2018, The Lancet OncologyCitation Excerpt :This small amount is often spent across multiple projects, meaning that the support for evaluative trials, or new palliative treatments, is insufficient. These figures are similar to those reported for 2010, when only 0·24% of cancer research spending in the UK went to palliative or end-of-life care, although the overall funding for research in cancer increased slightly.180 Similarly, in the USA, of the National Cancer Institute's total appropriation for 2010 of US$5 billion, only 1% was awarded to palliative care research.180
Alleviating the access abyss in palliative care and pain relief—an imperative of universal health coverage: the Lancet Commission report
2018, The LancetCitation Excerpt :The Lancet Commission on Essential Medicines put forward similar proposals, and our Commission strongly supports these recommendations and suggests working jointly, at least with respect to access to medicines for pain relief.336 Despite the increasing demand for palliative care and its documented health, social, and economic benefits, a very small proportion of resources for health-care research—just 0·2% of total resources for cancer research in the UK and 1% of the 2010 total appropriation of the US National Cancer Institute—is devoted to palliative care.337 Basic, clinical, and health-systems research could improve the effectiveness and selection of medicines and interventions involved in palliative care, disseminate generalisable findings, and identify practices and models that could be implemented and scaled up in LMICs.185,338
Palliative care: When and how, and what are the implications for global cancer policy?
2016, Journal of Cancer PolicyCitation Excerpt :In order to answer these questions, investment in research is necessary. Currently in the UK, less than 0.5% of the cancer research budget is allocated to research that aims to improve end-of-life cancer care [52]. In 2010 this money was allocated in 48 separate awards, providing an average of just £25,000 per award.
Failures in Health and Social Care: Governance and Culture Change
2023, Failures in Health and Social Care: Governance and Culture ChangeAdvanced heart failure: parenteral diuretics for breathlessness and peripheral oedema – systematic review
2022, BMJ Supportive and Palliative Care